Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Furosemide in COPD Exacerbation
NCT05769738Phase 3Unknown
- Sponsor
- American University of Beirut Medical Center
- Start
- Mar 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of furosemide in chronic obstructive pulmonary disease (COPD), sponsored by American University of Beirut Medical Center. Status: unknown.
02
Drugs
furosemide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05769738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05769738.